Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 18 04:00PM ET
27.72
Dollar change
-0.22
Percentage change
-0.79
%
IndexS&P 500 P/E77.13 EPS (ttm)0.36 Insider Own0.04% Shs Outstand5.65B Perf Week-2.29%
Market Cap156.53B Forward P/E10.19 EPS next Y2.72 Insider Trans0.13% Shs Float5.64B Perf Month0.76%
Income2.13B PEG- EPS next Q0.55 Inst Own70.12% Short Float1.17% Perf Quarter6.08%
Sales58.50B P/S2.68 EPS this Y20.52% Inst Trans0.53% Short Ratio1.45 Perf Half Y-18.64%
Book/sh15.77 P/B1.76 EPS next Y22.67% ROA1.01% Short Interest66.12M Perf Year-31.34%
Cash/sh2.25 P/C12.33 EPS next 5Y-1.20% ROE2.31% 52W Range25.61 - 42.22 Perf YTD-3.72%
Dividend Est.1.70 (6.14%) P/FCF32.66 EPS past 5Y-27.43% ROI1.39% 52W High-34.34% Beta0.59
Dividend TTM1.65 (5.95%) Quick Ratio0.69 Sales past 5Y10.96% Gross Margin48.99% 52W Low8.24% ATR (14)0.62
Dividend Ex-DateJan 25, 2024 Current Ratio0.91 EPS Y/Y TTM-93.20% Oper. Margin6.16% RSI (14)52.44 Volatility1.74% 2.04%
Employees88000 Debt/Eq0.84 Sales Y/Y TTM-41.70% Profit Margin3.65% Recom2.24 Target Price31.45
Option/ShortYes / Yes LT Debt/Eq0.72 EPS Q/Q-168.11% Payout439.41% Rel Volume0.79 Prev Close27.94
Sales Surprise-0.84% EPS Surprise163.21% Sales Q/Q-41.34% EarningsJan 30 BMO Avg Volume45.48M Price27.72
SMA201.48% SMA500.10% SMA200-13.67% Trades Volume36,143,539 Change-0.79%
Date Action Analyst Rating Change Price Target Change
Feb-23-24Initiated Guggenheim Buy $36
Jan-04-24Downgrade TD Cowen Outperform → Market Perform $32
Oct-20-23Resumed UBS Neutral $36 → $34
Oct-16-23Upgrade Jefferies Hold → Buy $38 → $39
Jul-17-23Reiterated JP Morgan Neutral $45 → $41
Jul-14-23Initiated HSBC Securities Buy $50
Jun-29-23Downgrade Credit Suisse Outperform → Neutral $47 → $40
May-11-23Downgrade Daiwa Securities Outperform → Neutral $38
Mar-06-23Initiated Jefferies Hold $43
Feb-07-23Upgrade Daiwa Securities Neutral → Outperform $51
Mar-18-24 03:39PM
03:28PM
02:59PM
11:12AM
05:49AM
05:17AM Loading…
05:17AM
03:09AM
Mar-17-24 02:49PM
02:36PM
08:50AM
Mar-16-24 05:51AM
Mar-15-24 12:51PM
09:30AM
09:00AM
05:50AM
02:16PM Loading…
Mar-14-24 02:16PM
12:26PM
10:30AM
10:27AM
05:25AM
Mar-13-24 05:45PM
09:54AM
08:39AM
04:00AM
Mar-12-24 02:26PM
02:26PM
01:20PM
09:09AM
07:11AM
06:55AM
06:45AM Loading…
06:45AM
Mar-11-24 12:44PM
10:33AM
09:45AM
09:28AM
Mar-10-24 07:10PM
02:01PM
09:35AM
08:36AM
06:35AM
Mar-09-24 01:09PM
10:06AM
01:59AM
Mar-08-24 04:38PM
02:41PM
11:15AM
Mar-07-24 07:09PM
09:21AM
Mar-06-24 07:42PM
01:08PM
12:02PM
Mar-05-24 01:54PM
10:00AM
09:13AM
02:56AM
Mar-04-24 08:28PM
01:45PM
09:00AM
06:21AM
05:21AM
01:00AM
Mar-03-24 07:30AM
Mar-02-24 01:10PM
10:42AM
08:45AM
Mar-01-24 09:48AM
07:20AM
07:00AM
Feb-29-24 11:31PM
05:40PM
05:39PM
05:15PM
11:30AM
08:31AM
08:00AM
08:00AM
04:10AM
03:12AM
02:52AM
Feb-28-24 06:46PM
06:18AM
Feb-27-24 09:00PM
11:43AM
10:45AM
07:25AM
05:40AM
Feb-26-24 10:00AM
09:18AM
Feb-24-24 02:32PM
06:15AM
Feb-23-24 12:21PM
05:51AM
05:43AM
12:07AM
Feb-22-24 04:00PM
02:21PM
11:22AM
11:00AM
06:10AM
Feb-21-24 07:48PM
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOURLA ALBERTChairman & CEOFeb 23 '24Option Exercise27.34127,6743,490,607439,748Feb 27 01:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23 '24Option Exercise27.3495,7552,617,942230,920Feb 27 01:46 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23 '24Option Exercise27.3463,8371,745,304218,148Feb 27 01:46 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23 '24Option Exercise27.3429,436804,780123,073Feb 27 01:46 PM
McDermott MichaelExecutive Vice PresidentFeb 23 '24Option Exercise27.3412,412339,34495,408Feb 27 01:47 PM
SAHNI PAYALExecutive Vice PresidentFeb 23 '24Option Exercise27.3411,527315,14834,604Feb 27 01:46 PM
DAMICO JENNIFER B.SVP & ControllerFeb 23 '24Option Exercise27.349,752266,62019,228Feb 27 01:46 PM
BOSHOFF CHRISTOFFELExecutive Vice PresidentFeb 23 '24Option Exercise27.349,752266,620148,703Feb 27 01:44 PM
Gottlieb ScottDirectorDec 15 '23Buy26.473,00079,4019,000Dec 19 09:31 AM
Gottlieb ScottDirectorMay 08 '23Buy38.581,00038,5806,000May 09 04:17 PM
Gottlieb ScottDirectorMay 05 '23Buy38.421,00038,4255,000May 09 04:17 PM